Fiess, Achim; Gissler, Sandra; Grabitz, Stephanie et al.
Fetal Growth Restriction Is Associated With Altered Optic Nerve Head Morphology in Term-Born Children and AdolescentsINVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. Bd. 66. H. 4. 2025
Wasserstein, Melissa; Gallagher, Renata C.; Barbato, Antonio et al.
Final results of the ASCEND trial: Continued or sustained improvements in hepatosplenomegaly, respiratory outcomes, and lipid profile after 4 years of olipudase alfa enzyme replacement therapy in adults with acid sphingomyelinase deficiencyMOLECULAR GENETICS AND METABOLISM. Bd. 144. H. 2. 2025
Buettner, Matthias
Financial toxicity-the financial burden of cancerONKOLOGIE. 2025
Reinhard, Soren; Utikal, Jochen Sven; Zaremba, Anne et al.
First-line checkpoint inhibitor therapy in metastatic acral lentiginous melanoma compared to other types of cutaneous melanoma: A multicenter study from the prospective skin cancer registry ADOREGEUROPEAN JOURNAL OF CANCER. Bd. 220. 2025
Piccinin, Claire; Aaronson, Neil K.; Bjordal, Kristin et al.
Flexibility in patient-reported outcome and health-related quality of life measurement: The EORTC Quality of Life Group measurement strategyEUROPEAN JOURNAL OF CANCER. Bd. 220. 2025
Linz, Valerie Catherine; Schmidt, Marcus; Hasenburg, Annette
Focusing on older patients with breast cancerGYNAKOLOGIE. 2025
Hartmann, Alica; Grabitz, Stephanie D.; Wild, Philipp S. et al.
Gender-specific changes in vision-related quality of life over time - results from the population-based Gutenberg Health StudyGRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY. 2025
Salah, Ahmed; Wollschlaeger, Daniel; Callari, Maurizio et al.
Genome-wide transcriptomic response of whole blood to radiationSCIENTIFIC REPORTS. Bd. 15. H. 1. 2025 S. 13
Kasan, Merve; Geyer, Florian H.; Siebenlist, Jana et al.
Genomic and phenotypic stability of fusion-driven pediatric sarcoma cell linesNATURE COMMUNICATIONS. Bd. 16. H. 1. 2025
Homey, Bernhard; Schelonke, Kathrin; Schlegel, Carla Marie et al.
German Cohort Observational Study to Investigate the Short- and Long-Term Safety and Clinical Effectiveness of Afamelanotide 16 mg (SCENESSE) in Patients With Erythropoietic Protoporphyria (EPP)PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE. Bd. 41. H. 2. 2025 S. 9